Clinical trial
Effect of Acetazolamide in Prevention of Contrast Nephropathy
NCT00634491 is registered in ClinicalTrials.gov with Shiraz University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Acetazolamide in Prevention of Contrast Nephropathy
- Lead sponsor
- Shiraz University of Medical Sciences
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- February 29, 2008
- Enrollment
- 240 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
contrast induced nephropathy